TailorMed is a technology company.
TailorMed is a healthcare technology company focused on improving patient affordability and access to care through financial navigation solutions.
TailorMed has raised $56.0M across 3 funding rounds.
TailorMed has raised $56.0M in total across 3 funding rounds.
TailorMed has raised $56.0M in total across 3 funding rounds.
TailorMed's investors include Cofounders Capital, Providence Ventures, Netalie Nadivi, 99 Startups, Bond, Bullpen Capital, Fuse, Imaginary Ventures, LAUNCH, Jake Kassan, Jamie Sutton, Kyle Widrick.
TailorMed is a health IT company founded in 2017 that builds an end-to-end platform to reduce patient financial toxicity by automating co-pay assistance, free drug programs, and financial navigation for providers, pharmacies, manufacturers, and patients[1][2][3]. It serves over 1,000 healthcare facilities nationwide, including hospitals, health systems, clinics, and specialty practices in oncology, rheumatology, and more, solving the problem of rising out-of-pocket costs that contribute to $140 billion in medical debt and $41 billion in uncompensated hospital care[2][5][6]. The platform uses algorithms to predict patient costs, match assistance from 6,000 resources, streamline enrollments, and provide analytics for KPIs like team productivity and patient savings, with strong growth evidenced by securing over $4 billion in patient assistance in 2023 and partnerships with life sciences covering 60+ brands[2][3][6].
TailorMed was founded in 2017 in New York by CEO Srulik Dvorsky, driven by a personal mission to remove financial barriers to care amid growing "financial toxicity" from high treatment costs, initially focusing on patients with chronic diseases but expanding as economic pressures affected broader populations[1][4][5]. The idea emerged from recognizing fragmented assistance processes between providers, pharmacies, pharma, and patients, leading to the creation of the largest U.S. network uniting these stakeholders with proprietary tech for data ingestion, cost prediction, and proactive outreach[2][4]. Early traction included helping 35 hospitals and 200 clinics by 2020, a pivotal 2021 merger with Vivor to scale the network and innovate solutions, and collaborations like the 2020 McKesson partnership for oncology practices[5][7].
TailorMed rides the healthcare affordability trend amid soaring costs, medical debt crises, and uncompensated care burdens, positioning as a coordinator in a fragmented ecosystem where providers, pharmacies, and pharma need digital networks for efficiency[2][4][6]. Timing aligns with post-pandemic economic instability, workforce shortages, and regulatory pushes for patient access, enabling TailorMed to centralize 6,000 resources and automate processes that manual navigation can't scale[3][6]. It influences the ecosystem by improving provider finances, boosting treatment adherence, and evolving from tech-only to hybrid services, fostering collaborations that set standards for financial navigation in value-based care[5][6][7].
TailorMed is poised to expand its patient-facing self-service tools for direct assistance search/enrollment, broaden beyond costs to other access barriers like SDOH, and deepen life science/pharmacy integrations amid rising demand for affordability solutions[2][6]. Trends like AI-driven predictions, hybrid tech-human models, and payer shifts will accelerate growth, potentially amplifying its network to dominate financial navigation as medical debt persists. This evolution from barrier-remover to full-journey enabler ties directly to its founding mission, positioning TailorMed to secure even greater patient savings and ecosystem efficiencies ahead[3][4][6].
TailorMed has raised $56.0M across 3 funding rounds. Most recently, it raised $28.0M Series B in November 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2024 | $28.0M Series B | Cofounders Capital, Providence Ventures, Netalie Nadivi | |
| Jun 1, 2021 | $20.0M Venture Round | 99 Startups, Bond, Bullpen Capital, Fuse, Imaginary Ventures, LAUNCH, Jake Kassan, Jamie Sutton, Kyle Widrick, Michael Lombardi, Ryan Duranso | |
| Jun 1, 2019 | $8.0M Series A | 99 Startups, Bond, Bullpen Capital, Cofounders Capital, Fuse, Imaginary Ventures, LAUNCH, Jake Kassan, Jamie Sutton, Kyle Widrick, Michael Lombardi, Ryan Duranso |